Skip to main content

Published locations for Fewer than 10% of eligible type 2 diabetes patients get new, pricey drugs

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Fewer than 10% of eligible type 2 diabetes patients get new, pricey drugs

User login

  • Reset your password
  • /content/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey-drugs
  • /clinicianreviews/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey
  • /familypracticenews/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey
  • /internalmedicinenews/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new
  • /clinicalendocrinologynews/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new
  • /ecardiologynews/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey
  • /cardiology/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey-drugs
  • /endocrinology/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey
  • /internalmedicine/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey
  • /familymedicine/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new-pricey
  • /type-2-diabetes-icymi/article/261506/diabetes/fewer-10-eligible-type-2-diabetes-patients-get-new